PREHOSPITAL ADMINISTRATION OF HEPARIN REDUCES THE RISK OF VESSEL OCCLUSION IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION: SECONDARY ANALYSIS OF THE TASTE TRIAL

Background: ST elevation myocardial infarction (STEMI) is most commonly caused by the rupture of a thin cap fibro-atheroma with subsequent thrombus formation and vessel occlusion. Percutaneous coronary intervention (PCI) with additive potent antithrombotic medication is the recommended therapy in